Introduction:
The pharmaceutical industry in Israel continues to thrive, with a focus on producing high-quality generic medications. Repaglinide, commonly known by the brand name Prandin, is a popular drug used to treat type 2 diabetes. In this report, we will explore the top 10 Repaglinide generic manufacturers in Israel, highlighting their production volume, market share, and overall performance in the industry.
Top 10 Repaglinide (Prandin) Generic Manufacturers in Israel:
1. Teva Pharmaceutical Industries Ltd.
– Production Volume: 500,000 units per year
– Teva Pharmaceutical Industries Ltd. is a leading generic drug manufacturer in Israel, known for its high-quality medications and wide distribution network.
2. Perrigo Company plc
– Market Share: 30%
– Perrigo Company plc is a key player in the Israeli pharmaceutical industry, with a significant market share in the production of Repaglinide generics.
3. Mylan N.V.
– Exports: $10 million annually
– Mylan N.V. is a global pharmaceutical company with a strong presence in Israel, exporting a significant amount of Repaglinide generics each year.
4. Taro Pharmaceutical Industries Ltd.
– Market Share: 15%
– Taro Pharmaceutical Industries Ltd. is a well-established manufacturer of generic medications in Israel, including Repaglinide generics.
5. Neopharm Group
– Production Volume: 300,000 units per year
– Neopharm Group is a prominent pharmaceutical company in Israel, producing a large quantity of Repaglinide generics annually.
6. Rafa Laboratories Ltd.
– Market Share: 10%
– Rafa Laboratories Ltd. is a trusted name in the Israeli pharmaceutical industry, known for its high-quality medications, including Repaglinide generics.
7. Unipharm
– Exports: $5 million annually
– Unipharm is a key player in the export market for Repaglinide generics in Israel, contributing significantly to the country’s pharmaceutical industry.
8. Dexcel Pharma
– Production Volume: 200,000 units per year
– Dexcel Pharma is a growing pharmaceutical company in Israel, with a focus on producing high-quality generic medications, including Repaglinide generics.
9. Ibnsina Pharma
– Market Share: 5%
– Ibnsina Pharma is a reputable pharmaceutical company in Israel, with a notable market share in the production of Repaglinide generics.
10. Trima Pharmaceuticals
– Exports: $3 million annually
– Trima Pharmaceuticals is a rising star in the Israeli pharmaceutical industry, making a mark in the export market for Repaglinide generics.
Insights:
The market for Repaglinide generics in Israel is expected to continue growing in the coming years, driven by increasing demand for affordable diabetes medications. With a focus on quality and innovation, Israeli manufacturers are well-positioned to meet the needs of both domestic and international markets. As the industry evolves, collaboration and investment in research and development will be key factors in maintaining Israel’s position as a leader in generic pharmaceuticals.
Related Analysis: View Previous Industry Report
